Edition:
India

Galmed Pharmaceuticals Ltd (GLMD.OQ)

GLMD.OQ on NASDAQ Stock Exchange Capital Market

14.01USD
1:30am IST
Change (% chg)

$-0.67 (-4.56%)
Prev Close
$14.68
Open
$14.75
Day's High
$14.86
Day's Low
$13.61
Volume
132,060
Avg. Vol
120,717
52-wk High
$27.06
52-wk Low
$3.61

Select another date:

Wed, May 9 2018

BRIEF-Galmed Pharmaceuticals Q1 Loss Per Share $0.17

* GALMED PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Galmed Pharmaceuticals To Report First Quarter 2018 Financial Results And Provide Business Update On Wednesday, May 9

* GALMED PHARMACEUTICALS TO REPORT FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE ON WEDNESDAY, MAY 9 Source text for Eikon: Further company coverage:

BRIEF-Galmed Pharmaceuticals Announces Pricing Of $6 Mln Registered Direct Offering

* ANNOUNCES PRICING OF $6.0 MILLION REGISTERED DIRECT OFFERING

BRIEF-Galmed Pharmaceuticals Files For Mixed Shelf Of Upto $150 Mln

* GALMED PHARMACEUTICALS LTD FILES FOR MIXED SHELF OF UPTO $150 MILLION - SEC FILING Source text: [https://bit.ly/2G8U5GO] Further company coverage:

BRIEF-Galmed Pharmaceuticals Q4 Loss Per Share $0.27

* GALMED PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Galmed Announces Arrive Study Data

* TOP-LINE RESULTS FROM ARRIVE TRIAL DID NOT MEET ITS PRIMARY ENDPOINT

BRIEF-Galmed Pharmaceuticals To Provide Corporate Update At The Leerink Partners 7Th Annual Global Healthcare Conference

* GALMED PHARMACEUTICALS TO PROVIDE CORPORATE UPDATE AT THE LEERINK PARTNERS 7TH ANNUAL GLOBAL HEALTHCARE CONFERENCE Source text for Eikon: Further company coverage:

BRIEF-Israeli Tax Authority Issues Tax Ruling On Galmed Pharma's Unit

* GALMED PHARMACEUTICALS -ISRAELI TAX AUTHORITY ISSUED TAX RULING GRANTING CO'S UNIT "PREFERRED TECHNOLOGICAL ENTERPRISE" STATUS, SUBJECT TO CONDITIONS

Select another date: